Figure 2).

A Exact date of persistence or absence of prophylactic pancreatic stents (PPS) in high-risk patients who developed moderate pancreatitis. PPS were proven to have passed from the pancreatic duct by the third day in seven patients with severe postendoscopic retrograde cholangiopancreatography pancreatitis (PEP) (11.9%). B Exact date of persistence or absence of PPS in high-risk patients who developed moderate PEP. PPS were proven to have passed from the pancreatic duct by the third day in five patients with moderate PEP (18.5%)